Cardiac Resynchronization Therapy in Heart Failure: Do Evidence-Based Guidelines Follow the Evidence?-Reference-Cited by-同舟云学术

Cardiac Resynchronization Therapy in Heart Failure: Do Evidence-Based Guidelines Follow the Evidence?

Published:2017-12 Issue:12 Volume:10 Page:
ISSN:1941-7713
Container-title:Circulation: Cardiovascular Quality and Outcomes
language:en
Short-container-title:Circ: Cardiovascular Quality and Outcomes

Author:

Almeida Nisha D.¹,Suarthana Eva¹,Dendukuri Nandini¹,Brophy James M.¹

Affiliation:

1. From the Technology Assessment Unit, McGill University Health Centre, Montreal, Canada (N.D.A., E.S., N.D.); and Division of Cardiology, Department of Medicine, McGill University, Montreal, Canada (J.M.B.).

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Link

https://www.ahajournals.org/doi/pdf/10.1161/CIRCOUTCOMES.117.003554

Reference10 articles.

1. Suarthana E Almeida N Dendukuri N. Cardiac resynchronization therapy in heart failure. February 22 2016 Report no. 77. Available at: http://www.mcgill.ca/tau/files/tau/muhc_tau_2016_77_biv_heart_failure.pdf. Accessed September 5 2017.

2. Cost-effectiveness of implantable cardiac devices in patients with systolic heart failure

3. An individual patient meta-analysis of five randomized trials assessing the effects of cardiac resynchronization therapy on morbidity and mortality in patients with symptomatic heart failure

4. Individual patient data network meta-analysis of mortality effects of implantable cardiac devices

5. Cardiac Resynchronization Therapy in Women

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An urgent in-hospital upgrade to resynchronization therapy is associated with lower likelihood of survival as compared to planned procedures;Kardiologia Polska;2022-11-30

2. QRS area as a predictor of cardiac resynchronization therapy response: A systematic review and meta‐analysis;Pacing and Clinical Electrophysiology;2022-01-29

3. The stricter criteria for Class I CRT indication suggested by the 2016 ESC Guidelines reliably exclude patients with a worse prognosis in comparison with the 2013 ESC indication criteria;International Journal of Cardiology;2018-12